CVS Health Corporation

CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs has 17.93B shares outstanding.

As of June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 95.50, indicating elevated leverage, while an interest coverage ratio of 4.13 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs posted a return on equity (ROE) of 6.23, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.42 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.91, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.75, useful for judging operating efficiency across full business cycles. The company generates approximately 1.38M in revenue per employee across its workforce of 300,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.32 indicates how many times CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs recorded 902.00M in income tax expense. That works out to an effective tax rate of 15.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 5.79B, leaving 4.89B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs generated 415.09B in revenue and converted that into 4.89B in net income, yielding earnings per share of 0.27. EBITDA reached 12.81B, while operating income came in at 14.01B.

As of June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs holds 13.96B in cash and equivalents against 76.31B in total debt, resulting in a net debt position of 50.08B. Total book value stands at 79.70B, with working capital of -11.69B providing operational flexibility.

CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs produced 14.78B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.02B in capital expenditures, free cash flow totaled 11.76B - equivalent to 0.66 per share.

Over the twelve months ended June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs posted a gross margin of 14.15, reflecting its pricing power and cost economics. The operating margin of 3.38 and net profit margin of 1.18 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, CVS Health Corp Shs Cert Deposito Arg Repr 0.0666666667 Shs paid dividends of 0.19 per share. The dividend payout ratio of 70.00 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.